Congo to receive 70,000 doses of Ervebo Ebola vaccine, which was effective in past outbreaks
Summary
Congo will get 70,000 doses of the Ervebo vaccine to help control the current Ebola outbreak. The vaccine works well for some Ebola viruses but its effectiveness against the Bundibugyo virus causing this outbreak is still being studied.Key Facts
- Congo is receiving 70,000 doses of the Ervebo Ebola vaccine.
- The vaccine is proven against some Ebola viruses but not yet for Bundibugyo virus, which is causing the current outbreak.
- So far, this outbreak infected 5,208 people and caused 2,476 deaths.
- Early tests suggest Ervebo might offer some protection against the Bundibugyo virus.
- 20,000 doses will be used in a clinical trial to study vaccine effects on this virus.
- The remaining 50,000 doses will be given to front-line health workers.
- This Ebola outbreak is spreading faster and killing more people than any previous outbreaks in Congo.
- The official outbreak started in May, but the virus likely began spreading in February from Mongbwalu.
Read the Full Article
This is a fact-based summary from The Actual News. Click below to read the complete story directly from the original source.
